Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
593.75
-4.00 (-0.67%)
Feb 3, 2025, 4:00 PM EST - Market closed
Thermo Fisher Employees
Thermo Fisher Scientific had 122,000 employees as of December 31, 2023. The number of employees decreased by 8,000 or -6.15% compared to the previous year.
Employees
122,000
Change (1Y)
-8,000
Growth (1Y)
-6.15%
Revenue / Employee
$351,467
Profits / Employee
$51,926
Market Cap
227.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 122,000 | -8,000 | -6.15% |
Dec 31, 2022 | 130,000 | 0 | - |
Dec 31, 2021 | 130,000 | 50,000 | 62.50% |
Dec 31, 2020 | 80,000 | 5,000 | 6.67% |
Dec 31, 2019 | 75,000 | 5,000 | 7.14% |
Dec 31, 2018 | 70,000 | 0 | - |
Dec 31, 2017 | 70,000 | 15,000 | 27.27% |
Dec 31, 2016 | 55,000 | 3,000 | 5.77% |
Dec 31, 2015 | 52,000 | 1,000 | 1.96% |
Dec 31, 2014 | 51,000 | 1,000 | 2.00% |
Dec 31, 2013 | 50,000 | 11,100 | 28.53% |
Dec 31, 2012 | 38,900 | -400 | -1.02% |
Dec 31, 2011 | 39,300 | 2,100 | 5.65% |
Dec 31, 2010 | 37,200 | 1,800 | 5.08% |
Dec 31, 2009 | 35,400 | 900 | 2.61% |
Dec 31, 2008 | 34,500 | 1,500 | 4.55% |
Dec 31, 2007 | 33,000 | 2,500 | 8.20% |
Dec 31, 2006 | 30,500 | 19,000 | 165.22% |
Dec 31, 2005 | 11,500 | 1,600 | 16.16% |
Dec 31, 2004 | 9,900 | -900 | -8.33% |
Dec 31, 2003 | 10,800 | -100 | -0.92% |
Dec 28, 2002 | 10,900 | -1,100 | -9.17% |
Dec 29, 2001 | 12,000 | -1,000 | -7.69% |
Dec 30, 2000 | 13,000 | -12,400 | -48.82% |
Jan 1, 2000 | 25,400 | 1,800 | 7.63% |
Jan 2, 1999 | 23,600 | 1,200 | 5.36% |
Jan 3, 1998 | 22,400 | 4,640 | 26.13% |
Dec 28, 1996 | 17,760 | 3,360 | 23.33% |
Dec 30, 1995 | 14,400 | 4,166 | 40.71% |
Dec 31, 1994 | 10,234 | 1,434 | 16.30% |
Jan 1, 1994 | 8,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AbbVie | 50,000 |
TMO News
- 4 days ago - Thermo Fisher Scientific: Finally Ready For A Breakout? (Upgrade) - Seeking Alpha
- 4 days ago - Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates - Investopedia
- 4 days ago - Thermo Fisher Scientific Inc. (TMO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Thermo Fisher beats quarterly estimates on strong demand for its tools and services - Reuters
- 4 days ago - Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 13 days ago - Biologicals Is The Future In Thermo Fisher: Buy Rating - Seeking Alpha
- 19 days ago - Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies - Business Wire
- 20 days ago - Thermo Fisher Scientific Inc. (TMO) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) - Seeking Alpha